GEMP expands NAFLD/NASH program to include pediatric NAFLD: https://globenewswire.com/news-release/2018/01/31/1329623/0/en/Gemphire-Announces-Initiation-of-Phase-2a-Clinical-Trial-of-Gemcabene-in-Pediatric-Non-Alcoholic-Fatty-Liver-Disease-NAFLD.html